论文部分内容阅读
目的:探究康复新液联合泮托拉唑在治疗消化性溃疡的临床效果。方法:选取独山县中医院在2014年4月至2016年3月收治的消化性溃疡患者49例作为研究对象,根据治疗方式的不同,将患者分为A组和B组。A组患者应用泮托拉唑进行治疗,B组患者在A组基础上应用康复新液进行治疗,对临床治疗效果进行比较分析。结果:B组的治疗总有效率明显高于A组,而B组患者出现的不良反应率明显比A组少,对两组患者各项指标进行比较,差异具有统计学意义(P<0.05)。结论:对消化性溃疡患者,使用康复新液联合泮托拉唑进行治疗,具有较为明显疗效。整体不良反应率低。
Objective: To investigate the clinical effect of Kangfuxin solution combined with pantoprazole in the treatment of peptic ulcer. METHODS: Forty-nine patients with peptic ulcer admitted from April 2014 to March 2016 in Dushan County Chinese Medicine Hospital were selected as study subjects. Patients were divided into group A and group B according to the different treatment methods. Patients in group A were treated with pantoprazole. Patients in group B were treated with Kangfuxin solution on the basis of group A, and their clinical effects were compared. Results: The total effective rate of treatment group B was significantly higher than that of group A, but the adverse reaction rate of group B was significantly less than that of group A, and the differences were statistically significant (P <0.05) . Conclusion: For patients with peptic ulcer, the use of Kangfuxin solution combined with pantoprazole for treatment has obvious curative effect. The overall adverse reaction rate is low.